{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T18:19:30Z","timestamp":1787768370671,"version":"build-2784847793"},"reference-count":80,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2014,8,19]],"date-time":"2014-08-19T00:00:00Z","timestamp":1408406400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0104303","type":"journal-article","created":{"date-parts":[[2014,8,19]],"date-time":"2014-08-19T13:53:56Z","timestamp":1408456436000},"page":"e104303","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":50,"title":["Safety of Hormonal Replacement Therapy and Oral Contraceptives in Systemic Lupus Erythematosus: A Systematic Review and Meta-Analysis"],"prefix":"10.1371","volume":"9","author":[{"given":"Adriana","family":"Rojas-Villarraga","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"July-Vianneth","family":"Torres-Gonzalez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1ngela-Mar\u00eda","family":"Ruiz-Sternberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2014,8,19]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1186\/ar3175","article-title":"The autoimmune tautology","volume":"12","author":"J-M Anaya","year":"2010","journal-title":"Arthritis Res Ther"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"J109","DOI":"10.1016\/j.jaut.2011.10.003","article-title":"Autoimmune disease and gender: plausible mechanisms for the female predominance of autoimmunity","volume":"38","author":"OL Quintero","year":"2012","journal-title":"J Autoimmun"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1258\/mi.2012.012019","article-title":"Treatment of premenstrual syndrome: a decision-making algorithm","volume":"18","author":"N Panay","year":"2012","journal-title":"Menopause Int"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"s1","DOI":"10.1210\/jc.2009-2509","article-title":"Postmenopausal hormone therapy: an Endocrine Society scientific statement","volume":"95","author":"RJ Santen","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.contraception.2012.08.029","article-title":"Trends in contraceptive use","volume":"87","author":"JE Darroch","year":"2013","journal-title":"Contraception"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.rbmo.2011.11.012","article-title":"Oestradiol valerate pretreatment in GnRH-antagonist cycles: a randomized controlled trial","volume":"24","author":"C Blockeel","year":"2012","journal-title":"Reprod Biomed Online"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1097\/gme.0b013e31820dc48d","article-title":"Pregnancy in a woman with premature ovarian insufficiency undergoing intracytoplasmic sperm injection after pretreatment with estrogens followed by therapy with estrogens associated with ovarian stimulation with gonadotropins: remarks about oocyte and emb","volume":"18","author":"M Tartagni","year":"2011","journal-title":"Menopause"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1001\/archderm.142.3.371","article-title":"Sex hormones and the genesis of autoimmunity","volume":"142","author":"LS Ackerman","year":"2006","journal-title":"Arch Dermatol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1002\/art.1780210413","article-title":"Sex effects in systemic lupus erythematosus: a clue to pathogenesis","volume":"21","author":"AT Masi","year":"1978","journal-title":"Arthritis Rheum"},{"key":"ref10","first-page":"17","article-title":"[The role of estrogen-androgen imbalance in rheumatic diseases]","volume":"62","author":"ZS Alekberova","year":"1990","journal-title":"Ter Arkh"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/00124743-199508000-00002","article-title":"Can Women with Systemic Lupus Erythematosus Safely Use Exogenous Estrogens?","volume":"1","author":"JP Buyon","year":"1995","journal-title":"J Clin Rheumatol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1258\/175404507780796433","article-title":"Systemic lupus erythematosus and hormone replacement therapy","volume":"13","author":"A Gompel","year":"2007","journal-title":"Menopause Int"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1080\/030097400750002003","article-title":"Hormone replacement therapy in women with rheumatic diseases","volume":"29","author":"H Julkunen","year":"2000","journal-title":"Scand J Rheumatol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1056\/NEJMc060035","article-title":"Oral contraceptives in women with systemic lupus erythematosus","volume":"354","author":"EB Schwarz","year":"2006","journal-title":"N Engl J Med"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1783\/147118901101195029","article-title":"Contraceptive practices in women with systemic lupus erythematosus and\/or antiphospholipid syndrome: what advice should we be giving?","volume":"27","author":"L Lakasing","year":"2001","journal-title":"J Fam Plann Reprod Health Care"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1084\/jem.147.6.1568","article-title":"Effect of castration and sex hormone treatment on survival, anti-nucleic acid antibodies, and glomerulonephritis in NZB\/NZW F1 mice","volume":"147","author":"JR Roubinian","year":"1978","journal-title":"J Exp Med"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/0896-8411(91)90048-H","article-title":"Differential effects of oestrogen in murine lupus: acceleration of glomerulonephritis and amelioration of T cell-mediated lesions","volume":"4","author":"H Carlsten","year":"1991","journal-title":"J Autoimmun"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"S190","DOI":"10.1002\/art.1780210932","article-title":"Study of the multiple factors in the pathogenesis of autoimmunity in New Zealand mice","volume":"21","author":"AD Steinberg","year":"1978","journal-title":"Arthritis Rheum"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1080\/08820130801973328","article-title":"Estrogen modulates bone marrow-derived DCs in SLE murine model-(NZB x NZW) F1 female mice","volume":"37","author":"B Jiang","year":"2008","journal-title":"Immunol Invest"},{"key":"ref20","first-page":"21","article-title":"Interleukin 2, T cell receptor and sex hormone studies in autoimmune mice","author":"N Talal","year":"1987","journal-title":"J Rheumatol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1615\/CritRevImmunol.v25.i2.30","article-title":"T- and B-cell abnormalities in systemic lupus erythematosus","volume":"25","author":"G Nagy","year":"2005","journal-title":"Crit Rev Immunol"},{"key":"ref22","first-page":"436","article-title":"Ovarian function and disease activity in patients with systemic lupus erythematosus","volume":"26","author":"SS Shabanova","year":"2008","journal-title":"Clin Exp Rheumatol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1002\/1529-0131(199906)42:6<1274::AID-ANR26>3.0.CO;2-B","article-title":"Ovarian failure and flares of systemic lupus erythematosus","volume":"42","author":"CC Mok","year":"1999","journal-title":"Arthritis Rheum"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"2761","DOI":"10.1002\/art.21263","article-title":"Use of a gonadotropin-releasing hormone analog for protection against premature ovarian failure during cyclophosphamide therapy in women with severe lupus","volume":"52","author":"EC Somers","year":"2005","journal-title":"Arthritis Rheum"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1177\/0961203307079300","article-title":"Risk factors for amenorrhea in juvenile systemic lupus erythematosus (JSLE): a Brazilian multicentre cohort study","volume":"16","author":"CAA Silva","year":"2007","journal-title":"Lupus"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1177\/0961203308094652","article-title":"Menstrual and hormonal alterations in juvenile systemic lupus erythematosus","volume":"18","author":"PB Medeiros","year":"2009","journal-title":"Lupus"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"e6409","DOI":"10.1136\/bmj.e6409","article-title":"Effect of hormone replacement therapy on cardiovascular events in recently postmenopausal women: randomised trial","volume":"345","author":"LL Schierbeck","year":"2012","journal-title":"BMJ"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1111\/j.1463-1326.2005.00545.x","article-title":"Meta-analysis: effect of hormone-replacement therapy on components of the metabolic syndrome in postmenopausal women","volume":"8","author":"SR Salpeter","year":"2006","journal-title":"Diabetes Obes Metab"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/j.amjmed.2009.05.021","article-title":"Bayesian meta-analysis of hormone therapy and mortality in younger postmenopausal women","volume":"122","author":"SR Salpeter","year":"2009","journal-title":"Am J Med"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1001\/jama.288.3.321","article-title":"Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women&apos;s Health Initiative randomized controlled trial","volume":"288","author":"JE Rossouw","year":"2002","journal-title":"JAMA"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"2962","DOI":"10.1161\/01.CIR.0000019406.74017.B2","article-title":"Statin therapy, cardiovascular events, and total mortality in the Heart and Estrogen\/Progestin Replacement Study (HERS)","volume":"105","author":"DM Herrington","year":"2002","journal-title":"Circulation"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1001\/jama.297.13.1465","article-title":"Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause","volume":"297","author":"JE Rossouw","year":"2007","journal-title":"JAMA"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"217","DOI":"10.3109\/13697137.2012.656401","article-title":"The timing hypothesis for coronary heart disease prevention with hormone therapy: past, present and future in perspective","volume":"15","author":"HN Hodis","year":"2012","journal-title":"Climacteric"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"e62329","DOI":"10.1371\/journal.pone.0062329","article-title":"Effect of hormone replacement therapy on cardiovascular outcomes: a meta-analysis of randomized controlled trials","volume":"8","author":"D Yang","year":"2013","journal-title":"PLoS One"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jclinepi.2009.06.006","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration","volume":"62","author":"A Liberati","year":"2009","journal-title":"J Clin Epidemiol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1002\/art.1780251101","article-title":"The 1982 revised criteria for the classification of systemic lupus erythematosus","volume":"25","author":"EM Tan","year":"1982","journal-title":"Arthritis Rheum"},{"key":"ref37","unstructured":"Howick J, Chalmers I, Glasziou P, Greenhalgh T, Heneghan C, <etal>et al<\/etal>.. (2011) Oxford Centre for Evidence-Based Medicine 2011 Levels of Evidence. OCEBM Levels Evid Work Gr. Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.cebm.net\/index.aspx?o=5653\" xlink:type=\"simple\">http:\/\/www.cebm.net\/index.aspx?o=5653<\/ext-link>."},{"key":"ref38","doi-asserted-by":"crossref","first-page":"d5928","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration&apos;s tool for assessing risk of bias in randomised trials","volume":"343","author":"JP Higgins","year":"2011","journal-title":"BMJ"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1002\/art.11105","article-title":"Sex hormones and systemic lupus erythematosus: review and meta-analysis","volume":"48","author":"RW McMurray","year":"2003","journal-title":"Arthritis Rheum"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1097\/AOG.0b013e3181ae9c64","article-title":"Safety of contraceptive method use among women with systemic lupus erythematosus: a systematic review","volume":"114","author":"KR Culwell","year":"2009","journal-title":"Obstet Gynecol"},{"key":"ref41","first-page":"487","article-title":"The use of sex hormones in women with rheumatological diseases","volume":"17","author":"RH Li","year":"2011","journal-title":"Hong Kong Med J"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"169","DOI":"10.2217\/ijr.10.11","article-title":"Oral contraceptives and risk of systemic lupus erythematosus","volume":"5","author":"E Vinet","year":"2010","journal-title":"Int J Clin Rheumtol"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s10067-007-0721-z","article-title":"Lupus nephritis and Raynaud&apos;s phenomenon are significant risk factors for vascular thrombosis in SLE patients with positive antiphospholipid antibodies","volume":"27","author":"K Choojitarom","year":"2008","journal-title":"Clin Rheumatol"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"2550","DOI":"10.1056\/NEJMoa051135","article-title":"Combined oral contraceptives in women with systemic lupus erythematosus","volume":"353","author":"M Petri","year":"2005","journal-title":"N Engl J Med"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"579","DOI":"10.3899\/jrheum.090824","article-title":"Noncalcified coronary plaque in systemic lupus erythematosus","volume":"37","author":"AN Kiani","year":"2010","journal-title":"J Rheumatol"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1177\/0961203308097475","article-title":"Hormone replacement therapy in women with systemic lupus erythematosus and risk of cardiovascular disease","volume":"18","author":"J Hochman","year":"2009","journal-title":"Lupus"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/RHU.0b013e318156bbf5","article-title":"Systemic lupus erythematosus in a multiethnic US cohort (LUMINA L II): relationship between vascular events and the use of hormone replacement therapy in postmenopausal women","volume":"13","author":"M Fern\u00e1ndez","year":"2007","journal-title":"J Clin Rheumatol"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"3070","DOI":"10.1002\/art.22855","article-title":"Menopause hormonal therapy in women with systemic lupus erythematosus","volume":"56","author":"J S\u00e1nchez-Guerrero","year":"2007","journal-title":"Arthritis Rheum"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1002\/art.22510","article-title":"Reproductive and menopausal factors and risk of systemic lupus erythematosus in women","volume":"56","author":"KH Costenbader","year":"2007","journal-title":"Arthritis Rheum"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"953","DOI":"10.7326\/0003-4819-142-12_Part_1-200506210-00004","article-title":"The effect of combined estrogen and progesterone hormone replacement therapy on disease activity in systemic lupus erythematosus: a randomized trial","volume":"142","author":"JP Buyon","year":"2005","journal-title":"Ann Intern Med"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1002\/art.10365","article-title":"Hormonal and reproductive risk factors for development of systemic lupus erythematosus: results of a population-based, case-control study","volume":"46","author":"GS Cooper","year":"2002","journal-title":"Arthritis Rheum"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1080\/03009749850154357","article-title":"Safety of hormonal replacement therapy in postmenopausal patients with systemic lupus erythematosus","volume":"27","author":"CC Mok","year":"1998","journal-title":"Scand J Rheumatol"},{"key":"ref53","first-page":"2149","article-title":"Hormone replacement therapy in systemic lupus erythematosus","volume":"24","author":"S Kreidstein","year":"1997","journal-title":"J Rheumatol"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"430","DOI":"10.7326\/0003-4819-122-6-199503150-00005","article-title":"Postmenopausal estrogen therapy and the risk for developing systemic lupus erythematosus","volume":"122","author":"J S\u00e1nchez-Guerrero","year":"1995","journal-title":"Ann Intern Med"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1177\/096120339400300104","article-title":"Safety of hormone replacement therapy (HRT) in systemic lupus erythematosus (SLE)","volume":"3","author":"NK Arden","year":"1994","journal-title":"Lupus"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1002\/art.24398","article-title":"Combined oral contraceptive use and the risk of systemic lupus erythematosus","volume":"61","author":"M-O Bernier","year":"2009","journal-title":"Arthritis Rheum"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"2539","DOI":"10.1056\/NEJMoa050817","article-title":"A trial of contraceptive methods in women with systemic lupus erythematosus","volume":"353","author":"J S\u00e1nchez-Guerrero","year":"2005","journal-title":"N Engl J Med"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1002\/art.1780400505","article-title":"Past use of oral contraceptives and the risk of developing systemic lupus erythematosus","volume":"40","author":"J Sanchez-Guerrero","year":"1997","journal-title":"Arthritis Rheum"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/0002-9378(85)90108-5","article-title":"Systemic lupus Erythematosus and reproductive function: A case control study","volume":"153","author":"D Grimes","year":"1985","journal-title":"Am J Obstet Gynecol"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1093\/oxfordjournals.aje.a117302","article-title":"Shingles, allergies, family medical history, oral contraceptives, and other potential risk factors for systemic lupus erythematosus","volume":"140","author":"BL Strom","year":"1994","journal-title":"Am J Epidemiol"},{"key":"ref61","first-page":"1515","article-title":"Postmenopausal estrogen replacement therapy and the risk of developing systemic lupus erythematosus or discoid lupus","volume":"25","author":"CR Meier","year":"1998","journal-title":"J Rheumatol"},{"key":"ref62","first-page":"213","article-title":"[Risk factors associated with systemic lupus erythematosis in a Mexican population]","volume":"44","author":"A Zonana-Nacach","year":"2002","journal-title":"Salud Publica Mex"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1093\/hmg\/ddp007","article-title":"Evaluation of imputation-based association in and around the integrin-alpha-M (ITGAM) gene and replication of robust association between a non-synonymous functional variant within ITGAM and systemic lupus erythematosus (SLE)","volume":"18","author":"S Han","year":"2009","journal-title":"Hum Mol Genet"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"604892","DOI":"10.1155\/2012\/604892","article-title":"Gender differences in the pathogenesis and outcome of lupus and of lupus nephritis","volume":"2012","author":"J Schwartzman-Morris","year":"2012","journal-title":"Clin Dev Immunol"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"iii2","DOI":"10.1093\/rheumatology\/ken150","article-title":"Oestrogens in rheumatic diseases: friend or foe?","volume":"47","author":"M Cutolo","year":"2008","journal-title":"Rheumatology (Oxford)"},{"key":"ref66","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1210\/er.2007-0001","article-title":"The complex role of estrogens in inflammation","volume":"28","author":"RH Straub","year":"2007","journal-title":"Endocr Rev"},{"key":"ref67","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1136\/ard.2006.060004","article-title":"Rheumatoid factor seropositivity is inversely associated with oral contraceptive use in women without rheumatoid arthritis","volume":"66","author":"SS Bhatia","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"ref68","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.yfrne.2012.01.001","article-title":"Multiple sclerosis: neuroprotective alliance of estrogen-progesterone and gender","volume":"33","author":"M Kipp","year":"2012","journal-title":"Front Neuroendocrinol"},{"key":"ref69","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1080\/03009740600844498","article-title":"Hormone replacement therapy may prevent the development of isolated pulmonary hypertension in patients with systemic sclerosis and limited cutaneous involvement","volume":"35","author":"L Beretta","year":"2006","journal-title":"Scand J Rheumatol"},{"key":"ref70","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.exer.2011.12.016","article-title":"Influence of sex hormones and genetic predisposition in Sj\u00f6gren&apos;s syndrome: a new clue to the immunopathogenesis of dry eye disease","volume":"96","author":"S Mostafa","year":"2012","journal-title":"Exp Eye Res"},{"key":"ref71","first-page":"63","article-title":"Drug-related Churg-Strauss syndrome?","volume":"17","author":"A Somogyi","year":"1998","journal-title":"Adverse Drug React Toxicol Rev"},{"key":"ref72","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1177\/039463200601900222","article-title":"Sjogren&apos;s syndrome in a celiac patient: searching for environmental triggers","volume":"19","author":"F D'Onofrio","year":"2006","journal-title":"Int J Immunopathol Pharmacol"},{"key":"ref73","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1111\/j.1538-7836.2004.00644.x","article-title":"Adverse effects of estrogen therapy in a subset of women with ITP","volume":"2","author":"K Onel","year":"2004","journal-title":"J Thromb Haemost"},{"key":"ref74","doi-asserted-by":"crossref","first-page":"611","DOI":"10.2169\/internalmedicine.49.2737","article-title":"Myasthenia gravis accompanied by premature ovarian failure and aggravation by estrogen","volume":"49","author":"Y Li","year":"2010","journal-title":"Intern Med"},{"key":"ref75","first-page":"903","article-title":"Hydroxylated estrogen metabolites influence the proliferation of cultured human monocytes: possible role in synovial tissue hyperplasia","volume":"26","author":"S Capellino","year":"2008","journal-title":"Clin Exp Rheumatol"},{"key":"ref76","doi-asserted-by":"crossref","unstructured":"Borenstein M, Higgins J, Rothstein H (2009) Introduction to Meta-Analysis. Statistics in Practice [Hardcover]. Wiley.","DOI":"10.1002\/9780470743386"},{"key":"ref77","unstructured":"Higgins J, Green S (2011) Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. Higgins JPT GS, editor The Cochrane Collaboration. Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.cochrane-handbook.org\" xlink:type=\"simple\">www.cochrane-handbook.org<\/ext-link>."},{"key":"ref78","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1093\/rheumatology\/32.3.227","article-title":"Contraceptive practice in women with systemic lupus erythematosus","volume":"32","author":"HA Julkunen","year":"1993","journal-title":"Br J Rheumatol"},{"key":"ref79","first-page":"S71","article-title":"Age at menopause and clinical characteristics","volume":"42","author":"J S\u00e1nchez-Guerrero","year":"1999","journal-title":"Arthritis Rheum"},{"key":"ref80","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1002\/acr.20608","article-title":"Efficacy of estrogen plus progestin on menopausal symptoms in women with systemic lupus erythematosus: a randomized, double-blind, controlled trial","volume":"63","author":"M-D-C Cravioto","year":"2011","journal-title":"Arthritis Care Res (Hoboken)"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0104303","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,13]],"date-time":"2019-08-13T23:47:49Z","timestamp":1565740069000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0104303"}},"subtitle":[],"editor":[{"given":"Amr H.","family":"Sawalha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2014,8,19]]},"references-count":80,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2014,8,19]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0104303","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,8,19]]}}}